Smith B J, Colman P M, Von Itzstein M, Danylec B, Varghese J N
Biomolecular Research Institute, Parkville, Victoria 3052, Australia.
Protein Sci. 2001 Apr;10(4):689-96. doi: 10.1110/ps.41801.
2,3-didehydro-2-deoxy-N:-acetylneuraminic acid (DANA) is a transition state analog inhibitor of influenza virus neuraminidase (NA). Replacement of the hydroxyl at the C9 position in DANA and 4-amino-DANA with an amine group, with the intention of taking advantage of an increased electrostatic interaction with a conserved acidic group in the active site to improve inhibitor binding, significantly reduces the inhibitor activity of both compounds. The three-dimensional X-ray structure of the complexes of these ligands and NA was obtained to 1.4 A resolution and showed that both ligands bind isosterically to DANA. Analysis of the geometry of the ammonium at the C4 position indicates that Glu119 may be neutral when these ligands bind. A computational analysis of the binding energies indicates that the substitution is successful in increasing the energy of interaction; however, the gains that are made are not sufficient to overcome the energy that is required to desolvate that part of the ligand that comes in contact with the protein.
2,3-二脱氢-2-脱氧-N-乙酰神经氨酸(DANA)是流感病毒神经氨酸酶(NA)的过渡态类似物抑制剂。为了利用与活性位点中保守酸性基团增加的静电相互作用来改善抑制剂结合,将DANA和4-氨基-DANA中C9位的羟基用胺基取代,这显著降低了这两种化合物的抑制剂活性。获得了这些配体与NA复合物的三维X射线结构,分辨率为1.4埃,结果表明两种配体与DANA等构结合。对C4位铵离子几何结构的分析表明,当这些配体结合时,Glu119可能呈中性。结合能的计算分析表明,这种取代成功地增加了相互作用能;然而,所获得的能量增益不足以克服使与蛋白质接触的配体部分去溶剂化所需的能量。